NCT04554732Early phase 1Completed
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia
A Study to Investigate Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Early phase 1
- Sponsor
- University of Arizona
- Participants (registry)
- 28
- Start
- April 2020
- Primary completion
- June 2022
- Study completion
- June 2022
- Last registry update
- December 2022
- Countries
- United States
Conditions studied: Alopecia, Chemotherapy-Induced Change, Hair Loss, Alopecia Drugs
Interventions: Keratinocyte growth factor
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.